Impact of Amikacin on Pseudothrombocytopenia

Publisher： Karger

E-ISSN： 1421-9662|137|1|27-29

ISSN： 0001-5792

Source： Acta Haematologica, Vol.137, Iss.1, 2016-11, pp. : 27-29

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Amikacin Treatment for Mycobacterium Marinum Infection

By  

THE JOURNAL OF DERMATOLOGY, Vol. 13, Iss. 5, 1986-10 ,pp. : 385-389

John Wiley & Sons Inc

Access to resources Recommend Favorite

Autoimmune Thrombocytopenia Complicated by EDTA- and/or Citrate-Dependent Pseudothrombocytopenia

By  

Transfusion Medicine and Hemotherapy, Vol. 42, Iss. 5, 2015-08 ,pp. : 345-348

Karger

Access to resources Recommend Favorite

The Prevalence and Biochemical Profiles of EDTA-Dependent Pseudothrombocytopenia in a Generally Healthy Population

By  

Acta Haematologica, Vol. 134, Iss. 3, 2015-05 ,pp. : 177-180

Karger

Access to resources Recommend Favorite

A novel method to prepare liposomes containing amikacin

By Zhang J. H.   Zhu J. B.  

Journal of Microencapsulation, Vol. 16, Iss. 4, 1999-07 ,pp. : 511-516

Informa Healthcare

Access to resources Recommend Favorite

Administration schedule and ototoxicity of amikacin in children with cancer

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 61, Iss. 2, 2014-02 ,pp. : 192-192

John Wiley & Sons Inc

Access to resources Recommend Favorite